Grant: MAYO CLINIC
Primary Recipient
MAYO CLINIC
Amount
$1,085,473.00
Award Date
4/28/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
Cigarette smoking is the single most important preventable cause of morbidity, mortality and excess health care costs in the United States and accounts for 30% of U.S. cancer deaths. Varenicline and bupropion SR (sustained-release) are non nicotine pharma
Recipients Connected to Award
Recipient | Role | Amount |
---|---|---|
MAYO CLINIC | Primary recipient | $776,684.00 |
REGENTS OF THE UNIVERSITY OF MINNESOTA | Sub-recipient | $308,789.00 |